Meitav Investment House’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-66,096
Closed -$1.15K 435
2021
Q1
$1.15K Buy
66,096
+354
+0.5% +$6.22K 0.03% 201
2020
Q4
$1.14M Sell
65,742
-60,537
-48% -$966K 0.04% 164
2020
Q3
$1.74M Sell
126,279
-17,007
-12% -$250K 0.09% 116
2020
Q2
$2.07M Buy
143,286
+25,743
+22% +$338K 0.12% 97
2020
Q1
$1.28M Buy
117,543
+12,509
+12% +$231K 0.1% 119
2019
Q4
$2.24M Buy
+105,034
New +$2.35M 0.16% 71

Other funds holding SBRA

Meitav Investment House's SBRA Position: Q2 2021 in Review

Meitav Investment House sold out of Sabra Healthcare REIT (SBRA) in Q2 2021, closing a stake of 66,096 shares — an estimated $1.15K sold.

Meitav Investment House first reported a position in SBRA in Q4 2019 and held it in 6 quarters. The position peaked at $2.24M in Q4 2019. 318 funds tracked by Wall St. Rank hold SBRA as of Q2 2021.

  • Meitav Investment House reported no remaining Sabra Healthcare REIT position as of Q2 2021 after selling out during the quarter.
  • Meitav Investment House sold 66,096 Sabra Healthcare REIT shares in Q2 2021, an estimated $1.15K.
  • Meitav Investment House first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 6 quarters.
  • Meitav Investment House's Sabra Healthcare REIT position peaked at $2.24M in Q4 2019.
  • 318 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2021.

Based on Meitav Investment House's 13F filing for Q2 2021, filed 5 Aug 2021.